Table 4.
Predictors of opioid use disorder treatment outcomes among Black adults receiving buprenorphine for opioid use disorder (n = 90)
| Treatment retention (y/n) | AOR (95% CI) | b | P value |
|---|---|---|---|
| Age | 1.05 (1.00, 1.10) | .05 | .039* |
| Women | 1.06 (.37, 3.05) | .06 | .887 |
| Mental health comorbidity | 2.90 (.97, 8.49) | 1.05 | .055 |
| Recent race-based discrimination | .86 (.21, 3.50) | −.15 | .823 |
| Recent substance use discrimination | .67 (.22, 2.08) | −.40 | .498 |
| Recent homelessness | .92 (.33, 2.58) | −.08 | .885 |
| History of injection opioid use | .22 (.08, .65) | −1.50 | .006* |
| Length of current treatment episode | 1.00 (.99, 1.00) | .00 | .879 |
| Substance use recurrence (out of 7 periods) | Beta (95% CI) | b | P value |
| Age | −.25 (−.96, .46) | −.09 | .488 |
| Women | −8.03 (−24.40, 8.35) | −.12 | .332 |
| Mental health comorbidity | −6.49 (−23.15, 10.18) | −.09 | .441 |
| Recent race-based discrimination | 5.56 (−17.03, 28.15) | .06 | .626 |
| Recent substance use discrimination | −4.88 (−22.65, 12.88) | −.06 | .586 |
| Recent homelessness | 4.88 (−10.92, 20.69) | .07 | .540 |
| History of injection opioid use | 10.87 (−4.57, 26.31) | .16 | .165 |
| Length of current treatment episode | −.026 (−.06, .01) | −.19 | .101 |
| Buprenorphine continuation (of 7 periods) | Beta (95% CI) | b | P value |
| Age | .61 (.08, 1.14) | .29 | .026* |
| Women | 7.28 (−4.97, 19.52) | .14 | .241 |
| Mental health comorbidity | 6.64 (−5.83, 19.11) | .12 | .292 |
| Recent race-based discrimination | 3.58 (−13.32, 20.48) | .05 | .674 |
| Recent substance use discrimination | −6.91 (−20.19, 6.38) | −.12 | .304 |
| Recent homelessness | 1.69 (−10.13, 13.52) | .03 | .776 |
| History of injection opioid use | −11.86 (−23.41, −.30) | −.23 | .044* |
| Length of current treatment episode | .01 (−.02, .03) | .06 | .611 |
*Indicates significant at p ≤.05